Tom D’Arcy

Potential role of miR-9 and miR-223 in recurrent ovarian cancer

Alexandros Laios, Sharon O’Toole, Richard Flavin et al. · Molecular Cancer · 2008 · 301 citations · Full text

Medicine, Cancer Biology, Oncology +17

A novel serum microRNA panel to discriminate benign from malignant ovarian disease

Ream Langhe, Lucy Norris, Feras Abu Saadeh et al. · Cancer Letters · 2014 · 81 citations · Full text

Medicine, Gynecology, Oncology +14

Pretreatment tumour volume measurement on high‐resolution magnetic resonance imaging as a predictor of survival in cervical cancer

W. P. Soutter, Joseph Hanoch, Tom D’Arcy et al. · BJOG An International Journal of Obstetrics & Gynaecology · 2004 · 69 citations

Medicine, Oncology, Radiology +12

The MyD88+ Phenotype Is an Adverse Prognostic Factor in Epithelial Ovarian Cancer

Charles J. d'Adhemar, Cathy Spillane, Michael Gallagher et al. · PLoS ONE · 2014 · 53 citations · Full text

Medicine, Immunology, Oncology +17

An integrative model for recurrence in ovarian cancer

Alexandros Laios, Sharon O’Toole, Richard Flavin et al. · Molecular Cancer · 2008 · 34 citations · Full text

Medicine, Gynecology, Oncology +17